Source disclosure: February 25, 2026
TSUMURA & CO. [4540.T]
TOKYO, Feb 25 (Pulse News Wire) — TSUMURA & CO. (4540.T) announced it will acquire its own shares through a tender offer.
The buyback is aimed at improving capital efficiency and enhancing shareholder returns.
TOKYO, Feb 25 (Pulse News Wire) -- Tsumura & Co., listed on the Tokyo Stock Exchange Prime Market under code number 4540.T, has announced significant corporate transactions involving its acquisition of shares in Yomeishu Manufacturing Co. Ltd., organizational restructuring, and related share transfers. The company's CEO, Shogo Kato, disclosed that these actions were approved by the board of directors on February 24, 2026.
The transaction involves four companies: Ren Co., Yomeishu Manufacturing Co. Ltd., Yuuzawa Co., and Tsumura & Co. A basic agreement contract was signed among all parties on February 24, 2026. Additionally, Ren Co., Yuuzawa Co., and Tsumura & Co. have also concluded a share transfer agreement related to this deal.
Under the terms of the public tender offer initiated by Ren Co., Yomeishu Manufacturing will be acquired through a squeeze-out procedure aimed at consolidating shareholders to only Ren Co. and Yuuzawa Co. Following the completion of the squeeze-out process, Ren Co. plans to transfer all acquired shares of Yomeishu Manufacturing to Yuuzawa Co. Subsequently, Yuuzawa Co. intends to distribute non-operational assets such as securities and real estate properties to shareholders via dividends or absorption mergers after becoming the sole shareholder of Yomeishu Manufacturing. These steps aim to streamline operations centered around key products like Yomeishu.
After completing the aforementioned procedures, Tsumura & Co. expects to acquire all shares held by Yuuzawa Co. in Yomeishu Manufacturing for approximately ¥68 billion between July and August 2026. This strategic move is part of Tsumura’s broader vision to enhance operational focus and resource allocation towards core healthcare product lines while leveraging synergies with Yomeishu Manufacturing’s strengths.
Yomeishu Manufacturing, headquartered in Shibuya, Tokyo, specializes in manufacturing and selling health beverages, alcoholic drinks, and pharmaceuticals. As of September 30, 2025, Yuuzawa Co. holds the largest stake at 23.70%, followed by other major shareholders including Nippon Life Trust Bank (Trust Account), Mitsubishi UFJ Trust and Banking Corporation, and Sumitomo Mitsui Banking Corporation. The capital stock stands at ¥1,650 million based on figures as of December 31, 2025.
The public tender offer began on February 25, 2026, and is scheduled to conclude on April 8, 2026, with an expected settlement date of April 15, 2026. Key milestones include the anticipated temporary shareholders' meeting in early June 2026 and subsequent phases leading up to the final share transfer to Tsumura & Co. between July and August 2026.
AI-translated content. 🟡 Confidence: Standard See terms • Original filing